Skip to main content
. Author manuscript; available in PMC: 2024 Dec 11.
Published in final edited form as: Drug Discov Today. 2018 May 7;23(6):1293–1304. doi: 10.1016/j.drudis.2018.05.012

Figure 1.

Figure 1

Overview of various conditions in which naringin has been described to display protective / therapeutic effects. For a more general description of the activity of naringin in these conditions, please see reference [21]. ROS – reactive oxygen species. CNS – central nervous system.